Development of variant-proof severe acute respiratory syndrome coronavirus 2, pan-sarbecovirus, and pan-β-coronavirus vaccines.
COVID-19
RBD
SARS-CoV-2
pan-sarbecovirus
pan-β-coronavirus
vaccines
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
revised:
19
09
2022
received:
24
08
2022
accepted:
20
09
2022
pubmed:
27
9
2022
medline:
11
1
2023
entrez:
26
9
2022
Statut:
ppublish
Résumé
The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with high transmission rates and striking immune evasion have posed a serious challenge to the application of current first-generation SARS-CoV-2 vaccines. Other sarbecoviruses, such as SARS-CoV and SARS-related coronaviruses (SARSr-CoVs), have the potential to cause outbreaks in the future. These facts call for the development of variant-proof SARS-CoV-2, pan-sarbecovirus or pan-β-CoV vaccines. Several novel vaccine platforms have been used to develop vaccines with broad-spectrum neutralizing antibody responses and protective immunity to combat the current SARS-CoV-2 and its variants, other sarbecoviruses, as well as other β-CoVs, in the future. In this review, we discussed the major target antigens and protective efficacy of current SARS-CoV-2 vaccines and summarized recent advances in broad-spectrum vaccines against sarbecoviruses and β-CoVs.
Identifiants
pubmed: 36161303
doi: 10.1002/jmv.28172
pmc: PMC9538210
doi:
Substances chimiques
COVID-19 Vaccines
0
Spike Glycoprotein, Coronavirus
0
spike protein, SARS-CoV-2
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e28172Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Nat Microbiol. 2022 Aug;7(8):1161-1179
pubmed: 35798890
Clin Infect Dis. 2022 Sep 14;75(5):893-896
pubmed: 35134167
Science. 2020 Aug 21;369(6506):1010-1014
pubmed: 32540901
Nature. 2021 Oct;598(7880):342-347
pubmed: 34464958
Nature. 2020 Dec;588(7838):498-502
pubmed: 32805734
Science. 2021 Aug 27;373(6558):991-998
pubmed: 34214046
Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):E7348-E7357
pubmed: 28807998
J Med Virol. 2023 Jan;95(1):e28172
pubmed: 36161303
Emerg Infect Dis. 2005 Jul;11(7):1016-20
pubmed: 16022774
Science. 2022 Aug 5;377(6606):eabq0839
pubmed: 35857620
Vaccines (Basel). 2022 Jun 16;10(6):
pubmed: 35746564
Nature. 2020 Aug;584(7819):120-124
pubmed: 32454512
Science. 2020 Dec 11;370(6522):1339-1343
pubmed: 33159009
Emerg Microbes Infect. 2020 Dec;9(1):2076-2090
pubmed: 32897177
Lancet Infect Dis. 2021 Aug;21(8):1107-1119
pubmed: 33773111
Cell Res. 2022 May;32(5):495-497
pubmed: 35210607
Nature. 2020 Oct;586(7830):578-582
pubmed: 32731258
N Engl J Med. 2020 Oct 15;383(16):1544-1555
pubmed: 32722908
Cell. 2021 Aug 5;184(16):4203-4219.e32
pubmed: 34242577
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
Cell. 2022 Feb 3;185(3):447-456.e11
pubmed: 35026151
Cell. 2020 Nov 25;183(5):1367-1382.e17
pubmed: 33160446
Trends Immunol. 2022 Mar;43(3):170-172
pubmed: 35125310
Lancet. 2020 Aug 15;396(10249):467-478
pubmed: 32702298
Trials. 2020 Oct 15;21(1):853
pubmed: 33059771
Nature. 2020 Jul;583(7815):290-295
pubmed: 32422645
J Virol. 2012 Apr;86(7):3995-4008
pubmed: 22278237
Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
NPJ Vaccines. 2021 Oct 28;6(1):129
pubmed: 34711815
Cell Mol Immunol. 2020 Jun;17(6):621-630
pubmed: 32415260
Drugs Today (Barc). 2008 Jan;44(1):63-73
pubmed: 18301805
Nature. 2022 Feb;602(7898):664-670
pubmed: 35016195
Travel Med Infect Dis. 2021 May-Jun;41:102026
pubmed: 33727175
Proc Natl Acad Sci U S A. 2021 Sep 21;118(38):
pubmed: 34470866
Lancet. 2021 Dec 11;398(10317):2173-2184
pubmed: 34774196
Nature. 2020 Oct;586(7830):567-571
pubmed: 32756549
Emerg Microbes Infect. 2022 Dec;11(1):1058-1071
pubmed: 35311493
Sci Immunol. 2020 Jun 11;5(48):
pubmed: 32527802
Virol Sin. 2020 Jun;35(3):340-343
pubmed: 32236815
Science. 2021 Feb 12;371(6530):735-741
pubmed: 33436524
Nat Commun. 2022 Oct 23;13(1):6309
pubmed: 36274085
JAMA. 2021 Jul 6;326(1):35-45
pubmed: 34037666
Immunity. 2021 Dec 14;54(12):2908-2921.e6
pubmed: 34788600
Antiviral Res. 2022 Aug;204:105370
pubmed: 35772601
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
Nat Rev Microbiol. 2009 Mar;7(3):226-36
pubmed: 19198616
Microorganisms. 2022 Jul 18;10(7):
pubmed: 35889169
Science. 2020 Jul 3;369(6499):77-81
pubmed: 32376603
Cell Rep Med. 2022 Jul 19;3(7):100679
pubmed: 35798000
Microorganisms. 2021 Jul 10;9(7):
pubmed: 34361915
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
Nature. 2022 Feb;602(7898):671-675
pubmed: 35016199
Nature. 2022 Feb;602(7898):682-688
pubmed: 35016197
Science. 2021 Feb 19;371(6531):759
pubmed: 33602830
J Virol. 2013 Sep;87(17):9939-42
pubmed: 23824801
Nature. 2020 Oct;586(7830):572-577
pubmed: 32726802
Viruses. 2020 Feb 25;12(3):
pubmed: 32106567
Virol Sin. 2018 Feb;33(1):104-107
pubmed: 29500691
Nature. 2013 Nov 28;503(7477):535-8
pubmed: 24172901
J Family Med Prim Care. 2021 Jul;10(7):2433-2435
pubmed: 34568116
Science. 2020 Aug 7;369(6504):731-736
pubmed: 32540900
N Engl J Med. 2022 Apr 21;386(16):1532-1546
pubmed: 35249272
Protein J. 2020 Jun;39(3):198-216
pubmed: 32447571
Lancet Infect Dis. 2021 May;21(5):637-646
pubmed: 33485468
Cell Rep. 2021 Dec 21;37(12):110143
pubmed: 34919799
Science. 2020 Feb 21;367(6480):
pubmed: 32079747
J Invest Dermatol. 2016 Nov;136(11):2183-2191
pubmed: 27287182
Nat Rev Immunol. 2021 Feb;21(2):73-82
pubmed: 33340022
Cell. 2020 Aug 6;182(3):722-733.e11
pubmed: 32645327
EMBO Rep. 2021 Aug 4;22(8):e52447
pubmed: 34142428
Expert Rev Vaccines. 2016 Sep;15(9):1123-34
pubmed: 26985862
Immunity. 2022 Jun 14;55(6):925-944
pubmed: 35623355
Expert Rev Vaccines. 2012 Dec;11(12):1405-13
pubmed: 23252385
Lancet. 2020 Aug 15;396(10249):479-488
pubmed: 32702299
J Med Virol. 2022 Oct;94(10):4628-4643
pubmed: 35705439
N Engl J Med. 2021 Sep 23;385(13):1172-1183
pubmed: 34192426
P T. 2008 Jan;33(1):35-41
pubmed: 19749990
Cell Mol Immunol. 2020 Oct;17(10):1095-1097
pubmed: 32895485
Lancet. 2020 Sep 26;396(10255):887-897
pubmed: 32896291
Cell Res. 2022 Mar;32(3):269-287
pubmed: 35046518
Viruses. 2020 Mar 25;12(4):
pubmed: 32218151
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
N Engl J Med. 2021 Apr 22;384(16):1577
pubmed: 33596349
Nat Rev Immunol. 2020 Oct;20(10):615-632
pubmed: 32887954
Cell. 2022 May 12;185(10):1728-1744.e16
pubmed: 35460644
Immunity. 2020 Dec 15;53(6):1272-1280.e5
pubmed: 33242394
Lancet Respir Med. 2022 Aug;10(8):739-748
pubmed: 35605625
Science. 2021 Sep 03;373(6559):1109-1116
pubmed: 34344823
Clin Microbiol Rev. 2022 Sep 21;35(3):e0001422
pubmed: 35862736
Nature. 2021 Jun;594(7864):553-559
pubmed: 33971664
Nature. 2020 Dec;588(7836):E6
pubmed: 33199918
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Lancet. 2022 Jan 15;399(10321):237-248
pubmed: 34953526
Lancet Reg Health West Pac. 2022 Mar 25;21:100440
pubmed: 35350464
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3048-53
pubmed: 26976607
EBioMedicine. 2022 Apr;78:103938
pubmed: 35305396
Vaccine. 2007 Apr 12;25(15):2832-8
pubmed: 17092615
Science. 2021 Oct 22;374(6566):472-478
pubmed: 34554826
Sci Adv. 2019 Apr 10;5(4):eaav4580
pubmed: 30989115
J Biol Chem. 2020 Sep 11;295(37):12910-12934
pubmed: 32661197
Immunity. 2023 Mar 14;56(3):669-686.e7
pubmed: 36889306
Lancet. 2020 Jun 13;395(10240):1845-1854
pubmed: 32450106
Biochem Biophys Res Commun. 2004 Nov 12;324(2):773-81
pubmed: 15474494
Nat Struct Mol Biol. 2021 Jun;28(6):478-486
pubmed: 33981021
N Engl J Med. 2022 Jun 2;386(22):2084-2096
pubmed: 35507508
J Cell Mol Med. 2021 Jan;25(2):1274-1289
pubmed: 33325143
N Engl J Med. 2020 Dec 10;383(24):2320-2332
pubmed: 32877576
N Engl J Med. 2020 Dec 17;383(25):2427-2438
pubmed: 32991794
Cell. 2020 Aug 6;182(3):713-721.e9
pubmed: 32778225
Protein Cell. 2022 Sep;13(9):655-675
pubmed: 34554412
Lancet Microbe. 2021 Jul;2(7):e285
pubmed: 33870240
mBio. 2012 Nov 20;3(6):
pubmed: 23170002
Emerg Microbes Infect. 2012 Aug;1(8):e13
pubmed: 26038424
Immunity. 2020 Dec 15;53(6):1315-1330.e9
pubmed: 33275896
Lancet. 2003 Oct 25;362(9393):1353-8
pubmed: 14585636
Cell. 2021 Aug 5;184(16):4220-4236.e13
pubmed: 34242578
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
Viruses. 2019 Jan 14;11(1):
pubmed: 30646569
Acta Pharm Sin B. 2022 Apr;12(4):1652-1661
pubmed: 34367893
Virology. 2009 Oct 10;393(1):144-50
pubmed: 19683779
Nat Med. 2022 Mar;28(3):490-495
pubmed: 35046573
Nat Rev Microbiol. 2016 Aug;14(8):523-34
pubmed: 27344959
Cell Discov. 2022 Jan 17;8(1):4
pubmed: 35034952
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
PLoS One. 2014 Nov 18;9(11):e112602
pubmed: 25405618
Nat Chem Biol. 2014 Dec;10(12):1043-8
pubmed: 25344812
Science. 2005 Sep 16;309(5742):1864-8
pubmed: 16166518
NPJ Vaccines. 2020 Sep 28;5:91
pubmed: 33083026
Nat Immunol. 2022 Jul;23(7):1008-1020
pubmed: 35761083
Science. 2020 May 29;368(6494):945-946
pubmed: 32385100
Nature. 2021 Feb;590(7846):386-388
pubmed: 33558746
BMJ. 2021 Sep 23;374:n2320
pubmed: 34556464
N Engl J Med. 2021 Aug 12;385(7):585-594
pubmed: 34289274
Nat Med. 2015 Dec;21(12):1508-13
pubmed: 26552008
Rev Med Virol. 2022 Sep;32(5):e2381
pubmed: 35856385
Nature. 2020 Dec;588(7839):682-687
pubmed: 33045718
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
Science. 2020 Jul 17;369(6501):330-333
pubmed: 32366695
Int J Pharm. 2021 Nov 20;609:121180
pubmed: 34637935
Cell Host Microbe. 2021 Apr 14;29(4):551-563.e5
pubmed: 33657424
Nat Microbiol. 2022 Jul;7(7):1063-1074
pubmed: 35773398
Lancet Infect Dis. 2021 Dec;21(12):1654-1664
pubmed: 34324836
Sci Immunol. 2021 Dec 10;6(66):eabj5129
pubmed: 34890255
Lancet. 2021 Mar 6;397(10277):881-891
pubmed: 33617777
Sci Transl Med. 2021 May 12;13(593):
pubmed: 33820835
Cell. 2021 Oct 14;184(21):5432-5447.e16
pubmed: 34619077
Cell. 2020 Aug 20;182(4):828-842.e16
pubmed: 32645326
J Immunol. 2005 Apr 15;174(8):4908-15
pubmed: 15814718
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Lancet Microbe. 2021 Oct;2(10):e494
pubmed: 34458880
Nat Med. 2022 Mar;28(3):486-489
pubmed: 35051989
Vaccine. 2021 Sep 15;39(39):5719-5726
pubmed: 34426024
Immunity. 2020 Jun 16;52(6):971-977.e3
pubmed: 32413330
Lancet. 2003 May 24;361(9371):1773-8
pubmed: 12781536
N Engl J Med. 2022 Jul 21;387(3):277-280
pubmed: 35793198
NPJ Vaccines. 2021 Oct 28;6(1):128
pubmed: 34711846
Signal Transduct Target Ther. 2020 Nov 27;5(1):282
pubmed: 33247109
Nature. 2021 May;593(7858):266-269
pubmed: 33767447
N Engl J Med. 2022 Jun 2;386(22):2097-2111
pubmed: 35507481
N Engl J Med. 2021 May 20;384(20):1885-1898
pubmed: 33725432
N Engl J Med. 2021 May 13;384(19):1824-1835
pubmed: 33440088
Viruses. 2022 Feb 28;14(3):
pubmed: 35336907
Nature. 2021 May;593(7857):130-135
pubmed: 33684923
Cell Rep. 2021 Feb 2;34(5):108699
pubmed: 33485405
N Engl J Med. 2020 Dec 17;383(25):2439-2450
pubmed: 33053279
Nat Rev Immunol. 2022 Apr;22(4):236-250
pubmed: 34312520
Adv Pharm Bull. 2022 Mar;12(2):219-236
pubmed: 35620327
Cell. 2022 Mar 3;185(5):896-915.e19
pubmed: 35180381
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Front Microbiol. 2020 Feb 28;11:298
pubmed: 32265848
Cell. 2020 Jun 11;181(6):1436-1441
pubmed: 32531248
Cell Res. 2022 Jul;32(7):601-602
pubmed: 35641566